Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

BD Unveils Nebraska-Based Manufacturing Capacity to Support U.S. Vaccination Agility and Preparedness

BD Unveils Nebraska-Based Manufacturing Capacity to Support U.S. Vaccination Agility and Preparedness

New Manufacturing Lines Will Provide U.S. Government with Priority Access to Hundreds of Millions of Needles and Syringes; Bolster Supply Readiness

BD and CerTest Biotec Announce CE Mark for Molecular Test to Detect, Identify Certain SARS-CoV-2 Variants

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec, today announced the CE mark for a molecular test that can detect and distinguish between the Alpha (B.1.1.7), Beta (B.1.351) and Gamma (P.1) SARS-CoV-2 variants. VIASURE SARS-CoV-2 Variant Real Time PCR Detection Kit for BD MAX™ can be used … Continued

BD On Location [VIDEO]

BD On Location is a video series about our enduring spirit throughout the COVID-19 pandemic. Join us as we showcase business leaders as they navigate reopening safely. Highlighting personal stories from medical experts, business executives, and other diverse voices, you’ll see what it takes to get back to business.

BD Receives Emergency Use Authorization for First At-Home COVID-19 Test to Use Smartphone to Interpret, Deliver Results

BD, a leading global medical technology company, announced today the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the BD Veritor™ At-Home COVID-19 Test — the first at-home COVID-19 rapid antigen test to use computer vision technology in a smartphone to interpret and provide a digital display of testing … Continued

BD and CerTest Biotec Announce CE Mark for Molecular Test to Detect, Identify Certain SARS-CoV-2 Variants

ZARAGOZA, SPAIN and FRANKLIN LAKES, N.J. (Aug. 6, 2021) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec, today announced the CE mark for a molecular test that can detect and distinguish between the Alpha (B.1.1.7), Beta (B.1.351) and Gamma (P.1) SARS-CoV-2 variants. VIASURE SARS-CoV-2 Variant Real … Continued

Driving healthcare worker safety through innovation across clinical workflows

The COVID-19 pandemic is the latest reminder that healthcare workers around the world face hazards related to their work every day, both visible and invisible. In many cases, medical devices and equipment are the primary means to prevent injury or disease.

‘BD On Location’ Spotlights Role COVID-19 Testing Plays in Getting Back to Business

As COVID-19 vaccination rates rise, government restrictions relax and businesses around the U.S. prepare to reopen, organizational leaders are exploring the path to “getting back to normal” that feels right for them, their associates, their customers, their industry and their community.

BD donates $300K to COVID-19 relief in India, totaling $2.8m in COVID-19 relief to date

At a time when COVID-19 cases were rising exponentially in India, the infrastructure of the healthcare system faced considerable challenges in its attempts to manage the surge. The region experienced shortages of critical medical treatments such as oxygen, and many patients were unable to get any type of treatment as hospitals were beyond capacity. In … Continued

USA Swimming Partners with BD to Provide COVID-19 Screening for the Olympic Trials and Other Competitive Swimming Events

USA Swimming and BD (Becton, Dickinson and Company), a leading global medical technology company, have partnered to provide COVID-19 testing at USA Swimming events. Specifically, rapid antigen tests using the BD Veritor™ Plus System will be conducted at the U.S. Olympic Team Trials – Swimming as an additional safety measure beyond the polymerase chain reaction (PCR) … Continued

BD Hits 2 Billion Injection Device Milestone in Support of Global COVID-19 Vaccination Efforts

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received pandemic orders for needles and syringes totaling 2 billion injection devices to support global COVID-19 vaccination efforts.